The data establish the first clinical proof-of-mechanism for RNA activation (RNAa) in a human monogenic disease, ...

Abogen Biosciences ("Abogen" or the "Group"), a clinical-stage biotechnology group pioneering RNA innovation, announced that ...

Lonza, the world's leading contract development and manufacturing organization (CDMO), and Asimov, the company building an AI ...

Suvoda, a global clinical trial technology company, announced a new release of important advancements since unifying the ...

Singapore imaging provider is the earliest site in the region to adopt a new generation of MRI technology. MR31 will enable ...

Earendil Labs, an AI-powered biotechnology company advancing next-generation biologics, today announced a research ...

In TRIUMPH-2, participants with obesity and type 2 diabetes taking retatrutide 12 mg lost an average of 49.6 lbs (20.8%) over ...

Sartorius and MAbSilico are collaborating to connect Al-driven protein discovery with automated, high-throughput cell line ...

Hengrui Pharma announced that it has entered into a license agreement with Novo Nordisk (Novo) for HRS-1596, a phase I-ready ...

FDA Fast Track designation granted for Telix's BiPASS® program, which is evaluating 68Ga-PSMA-PET imaging alongside MRI in ...

How this list was built Scope. Every biotech initial public offering with a first trading day between 1 January and 24 ...

The most consequential APAC biopharma deal of 2026 is Sun Pharma's all-cash agreement to buy Organon, which Sun describes as ...